Efficacy and safety of SGLT2 inhibitors in nondiabetic patients with CKD: a review of recent evidence

Background: Sodium-glucose cotransporter-2 inhibitors (SGLT2i) were initially developed as glucose-lowering agents in patients with type-2 diabetes. However, available data from clinical trials and meta-analyses suggest that SGLT2i have pleiotropic benefits in reducing mortality and delaying the pro...

Full description

Saved in:
Bibliographic Details
Main Authors: Junhao Lv (Author), Luying Guo (Author), Rending Wang (Author), Jianghua Chen (Author)
Format: Book
Published: Karger Publishers, 2023-04-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available